PHARMACIELO LTD (PCLO.CA) Stock Analyst Earnings Estimates
TSX-V:PCLO - TSX Venture Exchange - CA71716K1012 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.945M -26.71% | 5.309M 172.93% | 1.542M -70.96% | N/A | N/A | |
| EBITDA YoY % growth | -22.702M 43.57% | -8.948M 60.59% | -9.142M -2.17% | N/A | N/A | |
| EBIT YoY % growth | -23.959M 42.68% | -10.527M 56.06% | -10.556M -0.28% | 29.116M 375.82% | 42.869M 47.24% | |
| Operating Margin | -1,231.80% | -198.30% | -684.67% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -0.06 -20.00% | -0.03 | -0.03 | -98.02% |
| Q2 2021 Q2Q % growth | -0.04 42.86% | -0.03 | -0.01 | -32.01% |
| Q1 2021 Q2Q % growth | -0.05 28.43% | 0.05 | -0.10 | -199.01% |
| Q4 2020 Q2Q % growth | -0.16 -22.47% | 0.02 | -0.18 | -892.08% |
| Q3 2020 Q2Q % growth | -0.05 -26.23% | 0.01 | -0.06 | -595.05% |
| Q2 2020 Q2Q % growth | -0.07 36.18% | -0.04 | -0.03 | -73.27% |
| Q1 2020 Q2Q % growth | -0.07 -16.78% | -0.10 | 0.03 | 30.83% |
| Q4 2019 Q2Q % growth | -0.13 | -0.04 | -0.09 | -206.22% |
| Q3 2019 Q2Q % growth | -0.04 | -0.09 | 0.05 | 57.41% |
| Q2 2019 Q2Q % growth | -0.11 | -0.05 | -0.06 | -103.21% |
| Q1 2019 Q2Q % growth | -0.06 | -0.07 | 0.01 | 11.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.329M 277.85% | % | ||
| Q2 2024 Q2Q % growth | 783.7K 391.35% | % | ||
| Q1 2024 Q2Q % growth | 240.3K -69.45% | % | ||
| Q4 2023 Q2Q % growth | 244K -83.88% | % | ||
| Q3 2023 Q2Q % growth | 351.7K -26.00% | % | ||
| Q2 2023 Q2Q % growth | 159.5K -95.20% | % | ||
| Q1 2023 Q2Q % growth | 786.5K -34.52% | % | ||
| Q4 2022 Q2Q % growth | 1.513M 346.90% | % | ||
| Q3 2022 Q2Q % growth | 475.3K -2.04% | % | ||
| Q2 2022 Q2Q % growth | 3.32M 644.39% | % | ||
| Q1 2022 Q2Q % growth | 1.201M 77.88% | % | ||
| Q4 2021 Q2Q % growth | 338.6K -61.57% | % | ||
| Q3 2021 Q2Q % growth | 485.2K 1,773.36% | 529.24K | -44.04K | -8.32% |
| Q2 2021 Q2Q % growth | 446K -74.47% | 678.72K | -232.72K | -34.29% |
| Q1 2021 Q2Q % growth | 675.3K 31.28% | 6.56M | -5.885M | -89.71% |
| Q4 2020 Q2Q % growth | 881.1K 34.15% | 2.066M | -1.185M | -57.35% |
| Q3 2020 Q2Q % growth | 25.9K -80.09% | 1.608M | -1.582M | -98.39% |
| Q2 2020 Q2Q % growth | 1.747M | 141.4K | 1.606M | 1,135.50% |
| Q1 2020 Q2Q % growth | 514.4K | 707.01K | -192.61K | -27.24% |
| Q4 2019 Q2Q % growth | 656.8K | 135.906K | 520.894K | 383.28% |
| Q3 2019 Q2Q % growth | 130.1K | 643.602K | -513.502K | -79.79% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |